RNF149, demonstrated as a DEG between normal tissue and prostate cancer [49], was discovered to be associated with 2[18F]fluoro-2-deoxy-d-glucose (FDG) uptake during positron emission tomography (PET) and survival in non-small cell lung cancer patients [50]. This evidence concerns the gene RNF149 and prostate carcinoma.